[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-370194-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-370194-en":130},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","purine-rich-element-binding-protein-alpha-a-dnarna-binding-protein-with-multiple-roles-in-cancers","Purine-rich element binding protein alpha - a DNA/RNA binding protein with multiple roles in cancers","","Proteins that bind to DNA/RNA are typically evolutionarily conserved and control transcription initiation, mRNA translation, RNA stability, and RNA splicing. Dysregulation of purine-rich element binding protein alpha (PURα) disrupts signaling and contributes to cancer and other human diseases. Initially recognized as a tumor suppressor in acute myeloid leukemia and prostate cancer, PURα has since been shown to be aberrant in multiple cancers. Its oncogenic or suppressive effects involve RNA/protein interaction regulation, mRNA translation, stress granule formation, and transcriptional control. Emerging compound-targeting approaches highlight therapeutic potential.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/purine-rich-element-binding-protein-alpha-a-dnarna-binding-protein-with-multiple-roles-in-cancers/370194/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/purine-rich-element-binding-protein-alpha-a-dnarna-binding-protein-with-multiple-roles-in-cancers/370194.png","ImageObject",300,407,{"name":42,"@type":43},"Finn","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-11-04","2026-09-23",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",10,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"What biological processes are influenced by DNA/RNA binding proteins such as PURα?","Question",{"text":63,"@type":64},"DNA/RNA binding proteins regulate transcription initiation, mRNA translation, RNA stability, and RNA splicing. PURα dysregulation therefore impacts signaling and disease development.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"How do oncogenic or tumor-suppressive functions of PURα occur in cancers?",{"text":68,"@type":64},"PURα acts through regulating RNA/protein interactions, controlling mRNA translation, organizing stress granules, and modulating transcription of oncogenes and tumor suppressors.",{"name":70,"@type":61,"acceptedAnswer":71},"Why is PURα considered a biomarker and potential therapeutic target?",{"text":72,"@type":64},"Recent studies show PURα’s critical roles across multiple cancer types. Although direct targeting is challenging, preclinical strategies that identify PURα-directed compounds demonstrate promising anti-tumor efficacy.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},370194,1790702958,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,106,111,115,120,123,126],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":102,"doc_module":4,"doc_module_name":25,"category_name":103,"show_sort_weight":104,"slug":105},6,"Technology",50,"technology",{"id":107,"doc_module":4,"doc_module_name":25,"category_name":108,"show_sort_weight":109,"slug":110},7,"Healthcare",40,"healthcare",{"id":112,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":113,"slug":114},8,30,"research-report",{"id":116,"doc_module":4,"doc_module_name":25,"category_name":117,"show_sort_weight":118,"slug":119},9,"Religion & Spirituality",20,"religion-spirituality",{"id":118,"doc_module":4,"doc_module_name":25,"category_name":121,"show_sort_weight":118,"slug":122},"World Cup","world-cup",{"id":55,"doc_module":4,"doc_module_name":25,"category_name":124,"show_sort_weight":55,"slug":125},"Lifestyle","lifestyle",{"id":127,"doc_module":4,"doc_module_name":25,"category_name":128,"show_sort_weight":97,"slug":129},19,"General","general",{"code":4,"msg":82,"data":131},{"doc_id":79,"user_id":132,"nickname":42,"user_avatar":133,"doc_module":4,"category_id":112,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":55,"language":139,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":140,"faqs":141,"seo_title":142,"seo_description":12,"update_tm":143,"read_time":144,"preview_page_count":33,"preview_urls":145},34359740700684,"https://ap-avatar.wpscdn.com/avatar/1f400023980c374ae676?_k=1777273430885731487","Yu etal. Molecular Medicine (2025) 31:20 [https://doi.org/10.1186/s10020-025-01087-8](https://doi.org/10.1186/s10020-025-01087-8)  \nMolecular Medicine  \nREVIEW Open Access  \nPurine-rich element binding protein alpha: a DNA/RNA binding protein with multiple roles in cancers  \nShiyi Yu 1,2, Chengyang Jiang 1,2, Yawen Yang 1,2, Fei Cheng 1,2, Fangchen Liu 1,2, Chang Liu 1,2 and Xue Gong3*  \nAbstract  \nProteins that bind to DNA/RNA are typically evolutionarily conserved with multiple regulatory functions in transcription initiation, mRNA translation, stability of RNAs, and RNA splicing. Therefore, dysregulation of DNA/ RNA binding proteins such as purine-rich element binding protein alpha (PURα) disrupts signaling transduction and often leads to human diseases including cancer. PURα was initially recognized as a tumor suppressor in acute myeloid leukemia (AML) and prostate cancer (PC) . Most recently, several studies have revealed that PURα is dysregulated in multiple cancers, such as breast cancer (BC) and esophageal squamous cell carcinoma (ESCC) . The oncogenic or tumor-suppressive functions of PURα are realized via regulating RNA/protein interaction, mRNA translation, formation of stress granules (SGs), and transcriptional regulation of several oncogenes and tumor suppressors. Although DNA/RNA binding proteins are hardly targeted, novel strategies have been applied to identify compounds targeting PURα and have demonstrated promising anti-tumor efficacy in the preclinical study. The present review summarizes the most recently discovered critical roles of PURα in various cancer types, providing an overview of the biomarker and therapeutic target potential of PURα for patients with cancer. Keywords DNA/RNA binding protein, PURα, Cancer, Biomarker  \nIntroduction  \nThe human Purine-rich element-binding protein alpha (PURα) was first identified in 1992 by Bergemann, by deciphering DNA binding proteins of the purine-rich region in the c-Myc promoter (Bergemann and Johnson 1992). PURA is an evolutionarily conserved gene, with a similarity of > 99% in the encoded protein between  \n*Correspondence:  \nXue Gong  \n[18795899327@163.com](18795899327@163.com)  \n1Institute of Translational Medicine, Medical College, Yangzhou University, Yangzhou, Jiangsu, China  \n2Jiangsu Key Laboratory of Experimental & Translational Non-Coding RNA Research, Yangzhou University, Yangzhou, Jiangsu, China  \n3Nanjing Women and Children’s Healthcare Hospital, Maternal and Child Health Institute, Women’s Hospital of Nanjing Medical University, 123 Tianfei Alley, Mochou Road, Nanjing, China  \nhumans and mice (Ma et al. 1994). Since then, studies have focused on revealing PURα as a transcription factor in neurons, such as PURα stimulates the transcription of MBP in oligodendrocytic cells (Zambrano et al. 1997; Haas et al. 1995; Chen and Khalili 1995). Later, in 1998, Chepenik identified the interaction between PURα and RNA, which is critical for the self-association and DNAbinding activity of PURα (Chepenik et al. 1998). Further studies focus on unveiling how PURα regulates neural development and viral transcription, demonstrating that the direct interaction between RNA and PURα favors the transcription from DNA, promotes RNA-templated transcription, and enhances mRNA translation (Tretiakova et  \nal. 1998; Gallia et al. 1999, 2001; Kobayashi et al. 2000).  \nCancer is initiated by oncogenic cells which are featured with an array of attributes including genetic  \n© The Author(s) 2025. Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated ot","cbCaihGoLK166Nsz","https://ap.wps.com/l/cbCaihGoLK166Nsz","pdf",1611135,"English","# Abstract\n# Introduction","[{\"question\":\"What biological processes are influenced by DNA/RNA binding proteins such as PURα?\",\"answer\":\"DNA/RNA binding proteins regulate transcription initiation, mRNA translation, RNA stability, and RNA splicing. PURα dysregulation therefore impacts signaling and disease development.\"},{\"question\":\"How do oncogenic or tumor-suppressive functions of PURα occur in cancers?\",\"answer\":\"PURα acts through regulating RNA/protein interactions, controlling mRNA translation, organizing stress granules, and modulating transcription of oncogenes and tumor suppressors.\"},{\"question\":\"Why is PURα considered a biomarker and potential therapeutic target?\",\"answer\":\"Recent studies show PURα’s critical roles across multiple cancer types. Although direct targeting is challenging, preclinical strategies that identify PURα-directed compounds demonstrate promising anti-tumor efficacy.\"}]","Purine-rich element binding protein alpha - a DNA/RNA binding protein with multiple roles in cancers | PDF",1790187269,25,[146,150,154,158],{"page_no":22,"url":147,"width":148,"height":149},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/c1884e17e7b9794bb674b693bcf1e9b5.webp",983,1310,{"page_no":26,"url":151,"width":152,"height":153},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/448370a88782fd558d641f5547d2e6d8.webp",982,1309,{"page_no":30,"url":155,"width":156,"height":157},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/d725175fb0cd6c6b25d81aa1efa73c7c.webp",981,1308,{"page_no":33,"url":159,"width":160,"height":161},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/c635283d4698394d1e212f1e376b9aa4.webp",980,1306]